Showing results (1161-1170 of 1,437) with videos related to
Sort By:
Pageof 144
Cell Stem Cell|October 3, 2017
Jak1 Integrates Cytokine Sensing to Regulate Hematopoietic Stem Cell Function and Stress HematopoiesisMaria Kleppe, Matthew H Spitzer, Sheng Li, et al.Blood Cancer Journal|March 9, 2013
Mutations with epigenetic effects in myeloproliferative neoplasms and recent progress in treatment: Proceedings from the 5th International Post-ASH SymposiumA Tefferi, O Abdel-Wahab, F Cervantes, et al.Journal of Immunology (Baltimore, Md. : 1950)|August 8, 2008
CD28 costimulation is essential for human T regulatory expansion and functionTatiana N Golovina, Tatiana Mikheeva, Megan M Suhoski, et al.Blood Advances|May 23, 2020
Clonal hematopoiesis in angioimmunoblastic T-cell lymphoma with divergent evolution to myeloid neoplasmsNatasha E Lewis, Kseniya Petrova-Drus, Sarah Huet, et al.Leukemia|June 11, 2013
AKT is a therapeutic target in myeloproliferative neoplasmsI Khan, Z Huang, Q Wen, et al.The Journal of Clinical Investigation|January 18, 2014
Erythropoietin promotes breast tumorigenesis through tumor-initiating cell self-renewalBing Zhou, Jeffrey S Damrauer, Sean T Bailey, et al.The Journal of Clinical Investigation|September 21, 2010
HSP90 is a therapeutic target in JAK2-dependent myeloproliferative neoplasms in mice and humansSachie Marubayashi, Priya Koppikar, Tony Taldone, et al.Leukemia|October 20, 2019
Prognostic impact of RAS-pathway mutations in patients with myelofibrosisFabio P S Santos, Bartlomiej Getta, Lucia Masarova, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|July 31, 2020
Dual Targeting of Mesothelin and CD19 with Chimeric Antigen Receptor-Modified T Cells in Patients with Metastatic Pancreatic CancerAndrew H Ko, Alexander C Jordan, Evan Tooker, et al.The New England Journal of Medicine|December 12, 2017
Chimeric Antigen Receptor T Cells in Refractory B-Cell LymphomasStephen J Schuster, Jakub Svoboda, Elise A Chong, et al.Pageof 144